Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia

Lan Yang1 Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected];2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected]

Jing-Dong Zhou2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected];3 Department of Hematology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected]

Ting-Juan Zhang2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected];3 Department of Hematology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected]

Ji-Chun Ma1 Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected];2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected]

Gao-Fei Xiao1 Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected];2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected]

Qin Chen1 Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected];2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected]

Zhao-Qun Deng1 Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected];2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected]

Jiang Lin1 Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected];2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected]

Jun Qian2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected];3 Department of Hematology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected]Correspondence[email protected]

Dong-Ming Yao1 Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China, [email protected];2 The Key Laboratory of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China, [email protected], [email protected]Correspondence[email protected]

show all

Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia

Articles from other publishers (21)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia

Citations (21)

Articles from other publishers (21)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date